Catheter Precision Effectiveness Of 1-For-10 Reverse Stock Split Became Effective July 15, 2024
Portfolio Pulse from Benzinga Newsdesk
Catheter Precision, Inc. (NYSE:VTAK) has implemented a 1-for-10 reverse stock split effective July 15, 2024. The stock will trade on a split-adjusted basis under the same symbol 'VTAK' with a new CUSIP number 74933X 609.
July 15, 2024 | 3:05 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Catheter Precision, Inc. has executed a 1-for-10 reverse stock split, effective July 15, 2024. The stock will trade on a split-adjusted basis under the same symbol 'VTAK'.
Reverse stock splits are often used to increase the per-share price of a stock. This can attract institutional investors and meet exchange listing requirements. However, it does not change the company's market capitalization. The neutral score reflects the balance of potential positive and negative impacts.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100